NEUROGENE INC (NGNE) Stock Income Statement
NASDAQ:NGNE • US64135M1053
Current stock price
26.09 USD
-0.39 (-1.47%)
At close:
26.09 USD
0 (0%)
After Hours:
| 2025 (2025-12-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 925.00K | 0.00 | 0.00 | 0.00 | |||
| Operating Expenses | 103.23M | 83.43M | 55.58M | 59.10M | 60.70M | |||
| Research and Development | 74.91M | 60.82M | 44.39M | 41.13M | 39.16M | |||
| Selling, General, and Administrative Expenses | 28.32M | 22.61M | 11.19M | 17.97M | 21.54M | |||
| Operating Income | -103.23M | -82.50M | -55.58M | -59.10M | -60.70M | |||
| Interest Income/Expense | 11.54M | 8.46M | 2.94M | 1.58M | 18.00K | |||
| Other Income/Expense | 1.44M | -994.00K | -28.00K | -42.00K | -12.00K | |||
| Non Recurring Items | -100.00K | -100.00K | 16.36M | N/A | 0.00 | |||
| Income Before Taxes | -90.35M | -75.14M | -36.32M | -57.56M | -60.69M | |||
| Income Tax | 0.00 | N/A | N/A | N/A | N/A | |||
| Net Income | -90.35M | -75.14M | -36.32M | -57.56M | -60.69M | |||
| EBITDA | -100.19M | -79.31M | -52.32M | -57.54M | -59.39M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -4.24 | -4.28 | -2.83 | -104.26 | -110.34 | |||
| Non GAAP EPS | -4.29 | -4.27 | N/A | -20.80 | -21.90 | |||
| Statistics | ||||||||
| Profit Margin | N/A | -8123.68% | N/A | N/A | N/A | |||
| Operating Profit Margin | N/A | -8919.46% | N/A | N/A | N/A | |||
All data in USD